Clinical Trials for Mucosal Melanoma

Find clinical trials for mucosal melanoma. Discover research opportunities and treatment options in your area.

9 Active Trials Found

Showing 9 trials on this page

Page 1 of 1

Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery

NCT ID: NCT05111574

This clinical trial is looking at whether a combination of two medications, nivolumab and cabozantinib, can help prevent the return of mucosal melanoma after surgery. Mucosal melanoma is a type of ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Cleveland, Ohio, United States, Kalamazoo, Michigan, United States +174 more

A Phase II, Randomised Clinical Trial of Nivolumab and Ipilimumab Combined With Relatlimab for Patients With Resectable Advanced Melanoma Identified as Poor Responders to Immunotherapy Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)

NCT ID: NCT06999980

This clinical trial, called the Neo IRENIE trial, is exploring a new combination of immunotherapy treatments for patients with advanced melanoma that can be surgically removed. Specifically, it foc...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Wollstonecraft, New South Wales, Australia

A Beta-only IL-2 ImmunoTherapY Study

NCT ID: NCT05086692

This clinical trial, called the Beta-only IL-2 ImmunoTherapY Study, is looking to test a new treatment called MDNA11 for patients with advanced solid tumors, which are types of cancer that have spr...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Diego, California, United States, Baltimore, Maryland, United States +31 more

Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

NCT ID: NCT06319196

The Clear Me trial is a clinical study aimed at finding out if a new combination treatment for high-risk melanoma is more effective than the standard treatment. Specifically, the trial is looking a...

Recruiting

Phase: PHASE2 Type: interventional Locations: Toronto, Ontario, Canada

Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

NCT ID: NCT05384496

This clinical trial is studying the combination of two medications, axitinib and nivolumab, to see if they are effective and safe for treating advanced mucosal melanoma, which is a type of skin can...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Harrison, New York, United States

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

NCT ID: NCT05655312

This clinical trial is studying a new treatment called \[212Pb\]VMT01, which uses alpha particles to target a specific receptor (MC1R) in melanoma cells. The trial aims to find out how safe and eff...

Recruiting

Phase: PHASE1 Type: interventional Locations: Rochester, Minnesota, United States, Madison, Wisconsin, United States +11 more

A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors

NCT ID: NCT03611868

This clinical trial is investigating a new treatment called APG-115 for patients with advanced melanoma or other solid tumors that cannot be surgically removed. APG-115 works by blocking a protein ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Saint Louis, Missouri, United States, Durham, North Carolina, United States +20 more

A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma

NCT ID: NCT06424626

This clinical trial is investigating the safety and effectiveness of two experimental treatments, called AK104 and AK112, when used together with a drug named axitinib in patients who have advanced...

Not yet recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, , China

Single Arm Study of Induction Chemoradiotherapy Combined With Surgery in the Treatment of Locally Advanced SNMM

NCT ID: NCT05009446

This clinical trial is investigating a new treatment approach for a rare and aggressive type of cancer called sinonasal mucosal melanoma (SNMM). The study will explore how combining chemotherapy an...

Recruiting

Phase: EARLY_PHASE1 Type: interventional Locations: Shanghai, Shanghai, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions